Literature DB >> 33710023

Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis.

Thomas L Nickolas1, Jonathan Barasch1, Kenneth K Mugwanya2, Andrea D Branch3, Renee Heffron2,4, Valentine Wanga2, Nelly R Mugo2,5, Allan Ronald6, Connie Celum2,7, Deborah Donnell2, Jared M Baeten2,4,7, Christina M Wyatt8.   

Abstract

We previously reported a higher incidence of non-albumin proteinuria and a small but significant decline in estimated glomerular filtration rate (eGFR) among HIV-negative adults randomized to emtricitabine/tenofovir disoproxil fumarate preexposure prophylaxis (FTC/TDF PrEP) versus placebo. In a nested case--control study among participants randomized to FTC/TDF PrEP, established kidney injury biomarkers measured at 12 months were not significantly different between participants who subsequently experienced one of these kidney endpoints and randomly selected controls who did not.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33710023      PMCID： PMC8102362          DOI： 10.1097/QAD.0000000000002865

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.632


  9 in total

1.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

Authors:  Amanda Mocroft; Ole Kirk; Peter Reiss; Stephane De Wit; Dalibor Sedlacek; Marek Beniowski; Jose Gatell; Andrew N Phillips; Bruno Ledergerber; Jens D Lundgren
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

4.  Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.

Authors:  Thomas L Nickolas; Kai M Schmidt-Ott; Pietro Canetta; Catherine Forster; Eugenia Singer; Meghan Sise; Antje Elger; Omar Maarouf; David Antonio Sola-Del Valle; Matthew O'Rourke; Evan Sherman; Peter Lee; Abdallah Geara; Philip Imus; Achuta Guddati; Allison Polland; Wasiq Rahman; Saban Elitok; Nasir Malik; James Giglio; Suzanne El-Sayegh; Prasad Devarajan; Sudarshan Hebbar; Subodh J Saggi; Barry Hahn; Ralph Kettritz; Friedrich C Luft; Jonathan Barasch
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

5.  Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.

Authors:  Kenneth K Mugwanya; Christina Wyatt; Connie Celum; Deborah Donnell; Nelly R Mugo; Jordan Tappero; James Kiarie; Allan Ronald; Jared M Baeten
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

6.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.

Authors:  Frédéric-Antoine Dauchy; Sylvie Lawson-Ayayi; Renaud de La Faille; Fabrice Bonnet; Claire Rigothier; Nadia Mehsen; Ghada Miremont-Salamé; Charles Cazanave; Carine Greib; Francois Dabis; Michel Dupon
Journal:  Kidney Int       Date:  2011-05-04       Impact factor: 10.612

8.  Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.

Authors:  Kenneth Mugwanya; Jared Baeten; Connie Celum; Deborah Donnell; Thomas Nickolas; Nelly Mugo; Andrea Branch; Jordan Tappero; James Kiarie; Allan Ronald; Michael Yin; Christina Wyatt
Journal:  J Infect Dis       Date:  2016-03-29       Impact factor: 5.226

9.  Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.

Authors:  Marc M Solomon; Javier R Lama; David V Glidden; Kathleen Mulligan; Vanessa McMahan; Albert Y Liu; Juan Vicente Guanira; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; David N Burns; Robert M Grant
Journal:  AIDS       Date:  2014-03-27       Impact factor: 4.177
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.